We are live on ! Find out more
IART icon

Integra LifeSciences
IART

158 hedge funds and large institutions have $2B invested in Integra LifeSciences in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 8

12% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 51

10% more funds holding

Funds holding: 143 → 158 (+15)

3% less capital invested

Capital invested by funds: $2.06B → $2B (-$52.3M)

Holders
158
Holders Change
+15
Holders Change %
+10.49%
% of All Funds
4.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
57
Reduced
51
Closed
8
Calls
$347K
Puts
–
Net Calls
+$347K
Net Calls Change
+$10K

Top Buyers

Rank Fund Capital Flow
1
CRM
Cramer Rosenthal McGlynn
Connecticut
+$8.38M
2
Goldman Sachs
Goldman Sachs
New York
+$7.89M
3
BFA
BlackRock Fund Advisors
California
+$7.39M
4
TCM
Tributary Capital Management
Nebraska
+$4.68M
5
SCM
Snow Capital Management
Pennsylvania
+$4.32M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$35.7M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$15M
3
CI
Cambiar Investors
Colorado
-$5.48M
4
GAM
Gotham Asset Management
New York
-$5.4M
5
ECP
Elk Creek Partners
Colorado
-$3.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
Americafirst Capital Management
California
$575M -$227K -11,207 -30%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$236M +$3.39M +167,072 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$88M +$2.15M +106,113 +3%
BFA
4
BlackRock Fund Advisors
California
$79.8M +$7.39M +364,627 +11%
CIP
5
Champlain Investment Partners
Vermont
$78.4M +$4.07M +200,806 +6%
VNIM
6
Vaughan Nelson Investment Management
Texas
$75.9M -$696K -34,312 -1%
Wells Fargo
7
Wells Fargo
California
$56.4M -$347K -17,111 -0.7%
Victory Capital Management
8
Victory Capital Management
Texas
$46.6M +$732K +36,110 +2%
EIP
9
Epoch Investment Partners
New York
$45M -$112K -5,530 -0.3%
Goldman Sachs
10
Goldman Sachs
New York
$43.5M +$7.89M +388,989 +25%
WHG
11
Westwood Holdings Group
Texas
$41.2M -$263K -12,957 -0.7%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$40.9M +$2.96M +146,140 +9%
ClearBridge Investments
13
ClearBridge Investments
New York
$36.6M +$52.5K +2,589 +0.2%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$35.4M +$292K +14,390 +0.9%
BIT
15
BlackRock Institutional Trust
California
$35M -$260K -12,822 -0.8%
SAM
16
Silvercrest Asset Management
New York
$33.4M +$71.1K +3,506 +0.2%
CI
17
Cambiar Investors
Colorado
$32.2M -$5.48M -270,225 -16%
Fisher Asset Management
18
Fisher Asset Management
Washington
$29.1M -$590K -29,089 -2%
State Street
19
State Street
Massachusetts
$25.3M +$561K +27,655 +2%
Boston Partners
20
Boston Partners
Massachusetts
$21.2M -$895K -44,156 -4%
Ameriprise
21
Ameriprise
Minnesota
$19M +$4.3M +212,045 +33%
O
22
OppenheimerFunds
New York
$18.4M +$1.97M +97,204 +13%
Northern Trust
23
Northern Trust
Illinois
$15.8M -$761K -37,554 -5%
Norges Bank
24
Norges Bank
Norway
$15.5M +$4.17M +205,651 +42%
RFC
25
Russell Frank Company
Washington
$15.1M +$766K +37,774 +6%
1
2 3 4 5

IART Hedge Fund Activity: Q4 2014 in Review

158 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2014, worth a combined $2B — down 2.5% from $2.06B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new IART positions and 8 closed out — a net gain of 18 holders — while 57 added to existing stakes and 51 trimmed.

The largest buyer was Cramer Rosenthal McGlynn, opening a new position worth an estimated $8.38M. The largest seller was Invesco, cutting an estimated $35.7M.

  • 158 institutional investors held Integra LifeSciences (IART) as of Q4 2014, up from 143 in Q3 2014.
  • Funds reported $2B of Integra LifeSciences stock for Q4 2014, down 2.5% quarter-over-quarter.
  • 26 funds opened new Integra LifeSciences positions in Q4 2014 and 8 closed out, a net change of +18 holders.
  • The largest Integra LifeSciences buyer in Q4 2014 was Cramer Rosenthal McGlynn, an estimated $8.38M added.
  • The largest Integra LifeSciences seller in Q4 2014 was Invesco, an estimated $35.7M sold.

Based on aggregated 13F filings for Q4 2014.